AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 2.520
+0.140 (5.88%)
May 7, 2026, 3:56 PM HKT
AIM Vaccine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -675.46 | -277.23 | -1,301 | -319.6 | -692.77 |
Depreciation & Amortization | 151.71 | 165.46 | 169.18 | 163.41 | 142.24 |
Other Amortization | 6.62 | 6.57 | 5.52 | 3.03 | 2.06 |
Loss (Gain) From Sale of Assets | 0.46 | 0.14 | 7.15 | 0.69 | 0.21 |
Asset Writedown & Restructuring Costs | 525.77 | 32.75 | 1,785 | - | - |
Loss (Gain) From Sale of Investments | -0.01 | -0.08 | - | -3.07 | -1.67 |
Stock-Based Compensation | - | - | -14.2 | 225.76 | 952.13 |
Provision & Write-off of Bad Debts | -7.01 | -6.26 | 4.18 | 27.22 | 7.98 |
Other Operating Activities | 51.73 | 43.7 | -932.86 | -131.15 | 10.67 |
Change in Accounts Receivable | -66.83 | -112.43 | 43.35 | -16.16 | -201.77 |
Change in Inventory | 6.5 | 20.45 | -15.64 | -161.99 | -136.36 |
Change in Accounts Payable | 29.08 | -9.46 | -13.23 | 21.82 | 13.79 |
Change in Unearned Revenue | -17.71 | -21.65 | -0.26 | 16.12 | -28.91 |
Change in Other Net Operating Assets | 62.62 | 257.23 | 97.56 | 63.6 | 25.82 |
Operating Cash Flow | 67.47 | 99.19 | -165.5 | -110.32 | 93.4 |
Operating Cash Flow Growth | -31.97% | - | - | - | -62.69% |
Capital Expenditures | -114.41 | -121.75 | -158.92 | -779.01 | -1,125 |
Sale of Property, Plant & Equipment | 0.36 | 0.01 | 1.66 | 0.19 | 0.02 |
Cash Acquisitions | - | - | - | - | -250.38 |
Sale (Purchase) of Intangibles | -124.36 | -115.76 | -80.14 | -77.33 | -0.23 |
Investment in Securities | 87.01 | 51.96 | 8.12 | -56.93 | 5.9 |
Other Investing Activities | 43.66 | 23.2 | -42.69 | 54.93 | 32.55 |
Investing Cash Flow | -107.73 | -162.35 | -271.96 | -858.15 | -1,338 |
Long-Term Debt Issued | 1,204 | 1,089 | 1,458 | 1,282 | 537.83 |
Long-Term Debt Repaid | -1,326 | -1,054 | -1,048 | -452.86 | -261.04 |
Net Debt Issued (Repaid) | -122.77 | 34.63 | 410.27 | 829.16 | 276.79 |
Issuance of Common Stock | 70.06 | - | - | 162.02 | 553.48 |
Other Financing Activities | -58.94 | -60.85 | -48.2 | -10.8 | -42.24 |
Financing Cash Flow | -111.65 | -26.22 | 362.07 | 980.37 | 788.02 |
Foreign Exchange Rate Adjustments | 0.22 | 0.5 | 2.27 | -2.38 | - |
Net Cash Flow | -151.69 | -88.88 | -73.12 | 9.53 | -456.09 |
Free Cash Flow | -46.93 | -22.56 | -324.42 | -889.33 | -1,032 |
Free Cash Flow Margin | -4.03% | -1.75% | -27.32% | -70.35% | -65.73% |
Free Cash Flow Per Share | -0.04 | -0.02 | -0.27 | -0.74 | -0.89 |
Cash Interest Paid | 58.01 | 60.85 | 43.2 | 24.59 | 10.3 |
Cash Income Tax Paid | 11.84 | 17.98 | 0.92 | 59.57 | 90.03 |
Levered Free Cash Flow | -130.32 | 14.41 | -1,217 | -801.43 | -514.34 |
Unlevered Free Cash Flow | -94.17 | 52.4 | -1,189 | -785.37 | -507.65 |
Change in Working Capital | 13.66 | 134.14 | 111.78 | -76.6 | -327.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.